Liu, P., Zhao, L., Loos, F., Iribarren, K., Kepp, O., & Kroemer, G. (2018). Epigenetic anticancer agents cause HMGB1 release in vivo. Oncoimmunology.
Style de citation ChicagoLiu, Peng, Liwei Zhao, Friedemann Loos, Kristina Iribarren, Oliver Kepp, et Guido Kroemer. "Epigenetic Anticancer Agents Cause HMGB1 Release in Vivo." Oncoimmunology 2018.
Style de citation MLALiu, Peng, et al. "Epigenetic Anticancer Agents Cause HMGB1 Release in Vivo." Oncoimmunology 2018.
Attention : ces citations peuvent ne pas être correctes à 100%.